Browsing Tag
pharmaceuticals
9 posts
Leqembi gains traction in China as commercial insurance innovative drug list expands access for Alzheimer’s patients
Leqembi gains commercial insurance status in China, opening doors for Alzheimer’s patients and transforming access. Find out what this means for BioArctic AB and Eisai.
Can Sanofi Consumer Healthcare’s Q3 results validate its post-demerger growth promise?
Sanofi Consumer Healthcare India Q3 profit rises 40% with strong export recovery and relaunch of key brands. Find out how this impacts FY25 outlook.
Novartis makes $12bn bet on RNA medicine with Avidity Biosciences acquisition to expand rare-disease pipeline
Find out why Novartis’s $12 billion Avidity Biosciences deal marks a turning point for big pharma’s RNA-therapy ambitions.
Inside CapVest’s acquisition of STADA: What changes after Bain Capital and Cinven?
CapVest is acquiring majority control of STADA from Bain and Cinven. Find out how this move could reshape the pharma giant’s global growth strategy.
Wockhardt delivers strong FY25 EBITDA, but net loss persists amid US restructuring drag
Wockhardt posts a 67% EBITDA jump in FY25, but Q4 PAT remains negative. Find out how novel antibiotics like Zaynich and Miqnaf are shaping investor sentiment.
Sanjivani Paranteral achieves robust Q2 FY25 growth with 29.5% revenue surge
Sanjivani Paranteral Ltd, a pharmaceutical powerhouse based in Mumbai, has announced remarkable financial results for Q2 of the…
Novo Nordisk stock climbs 1.52% as obesity drug Liraglutide shows promise in young kids
Novo Nordisk A/S shares climbed by 1.52% today to 888.60 DKK, following the release of promising new data…
Acieta’s bold move: How acquiring Capital Industries will transform manufacturing
Acieta, a trailblazer in industrial robotic automation solutions, has announced a pivotal acquisition of Capital Industries, a renowned…
MOIL achieves historic production and sales milestones in FY24
In an unprecedented achievement, MOIL has announced its best-ever production figures for any financial year since the company’s…